Expression of type XVII collagen alpha 1 chain mRNA in the mouse heart. 1998

J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
First Department of Internal Medicine, Okayama University Medical School, Japan.

The type XVII collagen alpha 1 chain has been identified as a component of the type I hemidesmosome, and is thus thought to play a role in extracellular matrix (ECM) maintenance and signal transduction between the cell and the ECM. We examined the expression of type XVII collagen alpha 1 chain mRNA in the mouse heart by Northern blot analysis and determined the sequential changes of its expression in different developmental stages of the heart using the reverse transcriptase-polymerase chain reaction (RT-PCR) method. Northern blotting: Total RNA was extracted from 10 adult mouse hearts by the guanidine/cesium method. Hybridization was performed with mouse cDNA for alpha 1 (XVII) collagen. RT-PCR: Total RNA was extracted from 7 embryos, 4 neonates and 8 adult mice. Reverse transcription was performed using oligo-dT primer and MMLV. Amplification was carried out in alpha 1 (XVII) collagen and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). GAPDH served as an internal control. Northern blotting revealed a 5.6 kb signal that was identical to that of the alpha 1 (XVII) of skin and transformed keratinocyte reported previously. The sequences of the PCR products were also identical to those reported. The normalized expression ratios of alpha 1 (XVII) were 0.91 +/- 0.20 in the embryonic heart, 0.36 +/- 0.20 in the neonatal heart and 0.96 +/- 0.21 in the adult heart. In conclusion, we identified the expression of type XVII collagen alpha 1 chain mRNA in the mouse heart, suggesting that the type I hemidesmosome is located in the heart. The results of the RT-PCR at different developmental stages of the heart suggest that type XVII collagen contributes not only to cardiogenesis in the embryonic stage but also to maintenance of architecture and function in the adult heart.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003598 Cytoskeletal Proteins Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Proteins, Cytoskeletal
D005987 Glyceraldehyde-3-Phosphate Dehydrogenases Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD. GAPD,Glyceraldehyde-3-Phosphate Dehydrogenase,Glyceraldehydephosphate Dehydrogenase,Phosphoglyceraldehyde Dehydrogenase,Triosephosphate Dehydrogenase,Dehydrogenase, Glyceraldehyde-3-Phosphate,Dehydrogenase, Glyceraldehydephosphate,Dehydrogenase, Phosphoglyceraldehyde,Dehydrogenase, Triosephosphate,Dehydrogenases, Glyceraldehyde-3-Phosphate,Glyceraldehyde 3 Phosphate Dehydrogenase
D000071821 Dystonin A plakin characterized by repeat sequences homologous to SPECTRIN and PLECTIN and C-terminal EF HAND MOTIFS. It functions as an integrator of INTERMEDIATE FILAMENTS, ACTIN and MICROTUBULES in cytoskeleton networks. It is required for anchoring intermediate filaments to the actin cytoskeleton in neural and muscle cells as well as anchoring KERATIN-containing intermediate filaments to HEMIDESMOSOMES in EPITHELIAL CELLS. 230 kDa Bullous Pemphigoid Antigen,230-240 kDa Bullous Pemphigoid Antigen,Bullous Pemphigoid Antigen 1,Hemidesmosomal Plaque Protein,230 240 kDa Bullous Pemphigoid Antigen
D000097805 Collagen Type XVII A 220 kDa non-fibrillar collagen and basement membrane component. It is involved in healing wounds of the EPITHELIUM, CORNEAL. 180 kDa Bullous Pemphigoid Autoantigen,BP180 Antigen,BP180 Autoantigen,Bullous Pemphigoid Autoantigen, BP180,Collagen Alpha-1(XVII) Chain,Collagen XVII,Collagen, Type XVII, Alpha 1 Chain,Type XVII Collagen

Related Publications

J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
February 2024, BMC pulmonary medicine,
J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
June 1996, Journal of the American Society of Nephrology : JASN,
J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
May 1994, The Journal of biological chemistry,
J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
January 1993, The Biochemical journal,
J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
July 2006, Journal of dermatological science,
J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
April 2015, Human mutation,
J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
March 1998, Developmental dynamics : an official publication of the American Association of Anatomists,
J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
October 1993, Developmental dynamics : an official publication of the American Association of Anatomists,
J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
December 1991, The Journal of biological chemistry,
J Kondo, and S Kusachi, and Y Ninomiya, and H Yoshioka, and T Oohashi, and M Doi, and T Murakami, and H Moritani, and H Kumashiro, and T Tsuji
January 2017, Natural product communications,
Copied contents to your clipboard!